Drug Pricing On The Right Side Of The Inflation Debate

Drug Pricing On The Right Side Of The Inflation Debate – At The Wrong Time

20 Jul 2022

• By Michael McCaughan

The US pharmaceutical industry is finally on the right side of the inflation debate, with drug price increases clearly lagging well behind overall consumer price growth. It is, however, probably too late to make a difference in the prospects of price control legislation.

Rx inflation — • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images

It will likely end up as a bitter irony for the US pharmaceutical industry that draconian new price regulations – including inflation penalties – come to the US market at a time when drug price increases are lagging far behind other factors increasing costs for consumers.

The Pharmaceutical Research & Manufacturers of America trade association is doing its best to highlight the reality that there...